Predictors of Distant Metastasis and Prognosis in Newly Diagnosed T1 Intrahepatic Cholangiocarcinoma

被引:3
作者
Guo, Kaibo [1 ,2 ]
Lou, Yidan [1 ,3 ]
Zheng, Song [1 ,2 ,4 ]
机构
[1] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Sch Med, Dept Oncol, Hangzhou 310006, Peoples R China
[2] Zhejiang Univ, Affiliated Hangzhou Peoples Hosp 1, Sch Med, Key Lab Clin Canc Pharmacol & Toxicol Res Zhejiang, Hangzhou 310006, Peoples R China
[3] Zhejiang Univ, Sch Med, Hangzhou 310006, Peoples R China
[4] Zhejiang Univ, Affiliated Hangzhou Canc Hosp, Sch Med, Dept Oncol, Hangzhou 310006, Peoples R China
关键词
SURVIVAL; NOMOGRAM;
D O I
10.1155/2023/6638755
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background. According to American Joint Committee on Cancer (AJCC) 8th staging system, T1 intrahepatic cholangiocarcinoma (T1 ICC) is considered a tumor with no vascular invasion. However, T1 ICC usually occurs distant metastasis (DM), and the clinical features of these patients could help clinicians identify the high-risk population. Methods. We reviewed 1959 newly diagnosed patients with T1 ICC from the Surveillance, Epidemiology, and End Results (SEER) database during 2004-2018. Logistic regression models and Cox proportional hazards models were conducted to predict the risk of DM and overall survival (OS), respectively, and then, web-based nomograms were constructed. Decision curve analysis (DCA) and clinical impact curves (CIC) were used to measure the clinical utility of the models. The low-, medium-, and high-risk groups were identified by calculating the summary of the risk points. Nomograms on the web were also created to help clinicians better use these prediction models. Results. Tumor size and lymph node metastasis accounted for the first two largest proportions among the DM nomogram scores, while surgery, DM, age at diagnosis, chemotherapy, and lymph node metastasis occupied the largest percentage in OS nomogram. DM nomogram was established for these newly diagnosed patients with T1 ICC, and OS nomogram was developed to visually predict the OS rate of 3, 5, and 10 years. The calibration curves revealed a valid predictive accuracy of nomograms, of which the C-index was 0.703 and 0.740, respectively, for good discrimination. DCAs, CICs, and risk subgroups showed the clinical validity of these nomograms. Two websites were created to make it easier to use these nomograms. Conclusions. Novel web-based nomograms predicting the risk of DM and OS for T1 ICC were constructed. These predictive tools might help clinicians make precise clinical strategies for each patient with T1 ICC.
引用
收藏
页数:12
相关论文
共 24 条
[1]   Cohort contributions to trends in the incidence and mortality of intrahepatic cholangiocarcinoma [J].
Beal, Eliza W. ;
Tumin, Dmitry ;
Moris, Dimitrios ;
Zhang, Xu-Feng ;
Chakedis, Jeffery ;
Dilhoff, Mary ;
Schmidt, Carl M. ;
Pawlik, Timothy M. .
HEPATOBILIARY SURGERY AND NUTRITION, 2018, 7 (04) :270-276
[2]   Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma [J].
Bridgewater, John ;
Galle, Peter R. ;
Khan, Shahid A. ;
Llovet, Josep M. ;
Park, Joong-Won ;
Patel, Tushar ;
Pawlik, Timothy M. ;
Gores, Gregory J. .
JOURNAL OF HEPATOLOGY, 2014, 60 (06) :1268-1289
[3]   Cholangiocarcinoma [J].
Brindley, Paul J. ;
Bachini, Melinda ;
Ilyas, Sumera I. ;
Khan, Shahid A. ;
Loukas, Alex ;
Sirica, Alphonse E. ;
Teh, Bin Tean ;
Wongkham, Sopit ;
Gores, Gregory J. .
NATURE REVIEWS DISEASE PRIMERS, 2021, 7 (01)
[4]   Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma [J].
Burkhart, Richard A. ;
Pawlik, Timothy M. .
CANCER CONTROL, 2017, 24 (03)
[5]   Intrahepatic cholangiocardnoma - Rising frequency, improved survival, and determinants of outcome after resection [J].
Endo, Itaru ;
Gonen, Mithat ;
Yopp, Adam C. ;
Dalal, Kimberly M. ;
Zhou, Qin ;
Klimstra, David ;
DAngelica, Michael ;
DeMatteo, Ronald P. ;
Fong, Yuman ;
Schwartz, Lawrence ;
Kemeny, Nancy ;
O'Reilly, Eileen ;
Abou-Alfa, Ghassan K. ;
Shimada, Hiroshi ;
Blumgart, Leslie H. ;
Jarnagin, William R. .
ANNALS OF SURGERY, 2008, 248 (01) :84-96
[6]   RETRACTED: Association between Immunohistochemistry Markers and Tumor Features and Their Diagnostic and Prognostic Values in Intrahepatic Cholangiocarcinoma (Retracted Article) [J].
He, Jiannan ;
Zhang, Cao ;
Shi, Qinye ;
Bao, Fangping ;
Pan, Xiang ;
Kuai, Yue ;
Wu, Jingjin ;
Li, Li ;
Chen, Ping ;
Huang, Yian ;
Xu, Jianhong .
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
[7]   Surgical management of intrahepatic cholangiocarcinoma [J].
Hewitt, D. Brock ;
Brown, Zachary J. ;
Pawlik, Timothy M. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (01) :27-38
[8]   A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma An Eastern and Western Experience [J].
Hyder, Omar ;
Marques, Hugo ;
Pulitano, Carlo ;
Marsh, J. Wallis ;
Alexandrescu, Sorin ;
Bauer, Todd W. ;
Gamblin, T. Clark ;
Sotiropoulos, Georgios C. ;
Paul, Andreas ;
Barroso, Eduardo ;
Clary, Bryan M. ;
Aldrighetti, Luca ;
Ferrone, Cristina R. ;
Zhu, Andrew X. ;
Popescu, Irinel ;
Gigot, Jean-Francois ;
Mentha, Gilles ;
Feng, Shen ;
Pawlik, Timothy M. .
JAMA SURGERY, 2014, 149 (05) :432-438
[9]   Systemic therapies for intrahepatic cholangiocarcinoma [J].
Kelley, Robin Kate ;
Bridgewater, John ;
Gores, Gregory J. ;
Zhu, Andrew X. .
JOURNAL OF HEPATOLOGY, 2020, 72 (02) :353-363
[10]   Oncologic Impact of Lymph Node Dissection for Intrahepatic Cholangiocarcinoma: a Propensity Score-Matched Study [J].
Kim, Sung Hyun ;
Han, Dai Hoon ;
Choi, Gi Hong ;
Choi, Jin Sub ;
Kim, Kyung Sik .
JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (03) :538-544